| Literature DB >> 35457600 |
Clariano Pires de Oliveira Neto1,2,3, Rossana Santiago de Sousa Azulay1,2, Ana Gregória Ferreira Pereira de Almeida1, Maria da Glória Rodrigues Tavares1, Luciana Helena Gama Vaz4, Ianik Rafaela Lima Leal4, Monica Elinor Alves Gama5, Marizélia Rodrigues Costa Ribeiro5, Gilvan Cortês Nascimento1,2, Marcelo Magalhães2,6, Wellyandra Costa Dos Santos2,6, Alexandre Nogueira Facundo1,2, Manuel Dos Santos Faria2,3,6, Débora Cristina Ferreira Lago2,4.
Abstract
In the COVID-19 pandemic, there was an increase in consultations for precocious puberty. We aim to analyze differences in female puberty before and during the COVID-19 pandemic. A cross-sectional analytical study was designed at the Pediatric Endocrinology Clinic of the University Hospital of the Federal University of Maranhão in São Luis, Brazil. We included 55 girls with precocious puberty, 22 who started puberty during the pandemic and 33 who started puberty before the pandemic. Clinical, anthropometric, laboratory and imaging variables were compared between groups. Statistics were performed to determine if there was a statistical difference between the groups. Girls with puberty during the pandemic had higher Z-scores for weight (1.08 ± 1.29 versus 0.69 ± 0.83; p = 0.04), lower ovarian volume (1.88 ± 0.95 versus 3.15 ± 2.31; p = 0.01), and smaller differences between thelarche noticed by the parents and the diagnosis (6.63 ± 5.21 versus 12.15 ± 9.96; p = 0.02). The association between precocious puberty during the pandemic with higher Z-scores for weight, lower ovarian volume, and a reduction in the time between the perception of pubertal findings by parents and the diagnosis suggests the influence of the pandemic on the normal time of puberty.Entities:
Keywords: COVID-19; pandemic; precocious puberty
Mesh:
Year: 2022 PMID: 35457600 PMCID: PMC9031193 DOI: 10.3390/ijerph19084733
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Clinical and anthropometric characteristics of girls with precocious puberty before and during the COVID-19 pandemic (n = 55).
| Variable | Pre-Pandemic | During Pandemic | |
|---|---|---|---|
| M2 age (in years) | |||
| Mean ± SD | 6.74 ± 0.85 | 7.15 ± 0.71 | 0.10 T |
| Age at diagnosis (in years) | |||
| Mean ± SD | 7.86 ± 0.82 | 7.70 ± 0.62 | 0.22 T |
| Time from M2 to diagnosis (in months) | |||
| Mean ± SD | 12.15 ± 9.96 | 6.63 ± 5.21 | 0.02 M |
| Z-score to height | |||
| Mean ± SD | 0.22 ± 0.98 | 0.76 ± 1.19 | 0.07 M |
| GV (in cm/year) | |||
| Mean ± SD | 8.59 ± 2.30 | 9.35 ± 2.93 | 0.14 T |
| Z-score to weight | |||
| Mean ± SD | 0.69 ± 0.83 | 1.08 ± 1.29 | 0.04 M |
| Z-score to BMI | |||
| Mean ± SD | 0.75 ± 0.86 | 0.96 ± 1.34 | 0.07 M |
| Normal | 21 (63.64%) | 9 (40.91%) | 0.20 Q |
| Overweight | 6 (18.18%) | 5 (22.73%) | |
| Obesity | 6 (18.18%) | 8 (36.36%) | |
| Tanner Stage | 0.16 E | ||
| 2 | 12 (36.36%) | 7 (31.82%) | |
| 3 | 18 (54.56%) | 15 (68.18%) | |
| 4 | 3 (9.09%) | 0 |
M2—Telarche; GV—Growth velocity; SD—Standard deviation; T—Test for independent samples; M—Mann–Whitney; Q—Chi-square; E—Fisher’s exact.
Laboratory and radiological characteristics of girls with precocious puberty before and during the COVID-19 pandemic (n = 55).
| Variable | Pre Pandemic | During Pandemic | |
|---|---|---|---|
| BA (in years) | |||
| Mean ± SD | 9.82 ± 1.19 | 9.55 ± 1.34 | 0.19 M |
| BA–CA (in years) | |||
| Mean ± SD | 1.96 ± 0.87 | 1.87 ± 1.00 | 0.36 T |
| LH (IU/L) | |||
| Mean ± SD | 1.35 ± 1.72 | 1.28 ± 2.17 | 0.45 M |
| FSH (IU/L) | |||
| Mean ± SD | 4.11 ± 2.64 | 4.33 ± 3.05 | 0.36 M |
| Estradiol (pmol/L) | |||
| Mean ± SD | 27.44 ± 18.80 | 25.61 ± 15.97 | 0.40 M |
| Ovarian Volume (mL) | |||
| Mean ± SD | 3.15 ± 2.31 | 1.88 ± 0.95 | 0.01 M |
BA—Bone age; CA—Chronological age; SD—Standard deviation; LH—Luteinizing hormone; FSH—Follicle-stimulating hormone; T—T test for independent samples; M—Mann–Whitney.
Figure 1Ovarian ultrasound of a girl diagnosed with precocious puberty during the COVID-19 pandemic showing a reduced pubertal ovary. The patient started puberty at 7 years and 3 months (May 2020); August 2020: height 1.67 SDS, weight 1.53 SDS, BMI 1.1 SDS, Tanner stage 3.